Models, signals, and distributed bio-behavioral control of exercise in diabetes
糖尿病运动的模型、信号和分布式生物行为控制
基本信息
- 批准号:8971447
- 负责人:
- 金额:$ 297.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAdherenceAlgorithmsArchitectureArtificial PancreasAutomationBehavior ControlBlood GlucoseCarbohydratesCellular PhoneClinical TrialsComplexDataData AnalysesData CollectionDatabasesDecision Support SystemsDetectionDevelopmentDevicesDiabetes MellitusDoseEcosystemEducationEnsureExerciseExposure toFaceFeasibility StudiesFeedbackFrightGlucoseHearingHeart RateHome environmentHourHumanHyperglycemiaHypoglycemiaIllinoisInjection of therapeutic agentInpatientsInstitutesInsulinInsulin-Dependent Diabetes MellitusIntakeLeadLeftLifeMedical DeviceMetabolicModelingMonitorNamesPatientsPatternPhilosophyPhysical activityPhysiologicalPhysiologyPumpResearchResearch InfrastructureRiskRunningSafetySignal TransductionSpecificitySystemTechnologyTestingTimeUniversitiesUpdateValidationVariantVirginiabaseblood glucose regulationclinically relevantcloud baseddesigndetectorempoweredfeedingfitnessglycemic controlimprovednovelpancreas developmentprogramspsychosocialpublic health relevancesafety studysensorsimulation
项目摘要
DESCRIPTION (provided by applicant): Physically active patients with type 1 diabetes (T1D) face a very specific challenge in their management of glycaemia: physical activity can dramatically alter glucose homeostasis both acutely and over a period of several hours. The magnitude of this behaviorally triggered physiological disturbance is highly variable and depends on a number of factors such as insulin- on-board, prandial state, and fitness to name only a few. These complex interactions and associated fear of hypoglycemia often lead to avoidance of physical activity. We propose to address this specific hurdle of living with diabetes by empowering patients through a network of medical devices, assembled into an adaptive artificial pancreas (AP) platform, tailored to the needs and choices of each patient. This project unites two leading groups in artificial pancreas development, the University of Virginia Center for
Diabetes Technology and the Illinois Institute of Technology Center for Diabetes Research and Education. We propose to leverage our extensive technology portfolio in AP platform, closed loop algorithms, exercise detection and quantification, and modelling to address the following specific aims: 1. Patient-specific exercise risk alert system informing patients at the onset of exercise of likely hypoglycemia based on: (i) tuning a risk detector to each patient using DiAs cloud functionalities, and (ii) personalized simulation-based advice on treatment adaptation. 2. Exercise-informed automated insulin dosing: Upgrade to AP control system using exercise sensing to track metabolic risk and adjust insulin to maintain safe BG levels. 3. Fully-integrated Exercise-adapted AP system: We hypothesize that an exercise-informed AP system with both feed-forward (1) and feedback (2) components, freeing the patient from obligatory additional devices will improve glycemic safety and technology acceptance. We will demonstrate feasibility, safety, and efficacy of each of the proposed modules, independently and in concert, through three human clinical trials: two short term inpatient demonstration trials and one final longer term (4 months) home trial. This final trial will also explore psychosocial aspects of exercising with our platform, and start addressing key aspects of safety, accounting for adherence and technology acceptance of such a complex system. We expect the proposed system to enhance the safety and efficacy of AP in real life conditions. By creating a novel data infrastructure and optimal exercise control algorithms, this project has also the potential to generate clinically relevant derivatives for other mode of treatment.
描述(由申请人提供):经常运动的 1 型糖尿病 (T1D) 患者在血糖管理方面面临着非常特殊的挑战:体力活动可以在几个小时内急剧改变血糖稳态。引发的生理紊乱变化很大,取决于多种因素,例如胰岛素、膳食状态和健康状况等,这些复杂的相互作用和相关的低血糖恐惧常常导致回避。我们建议通过医疗设备网络为患者提供帮助,将其组装成人工适应性胰腺(AP)平台,根据每位患者的需求和选择来解决糖尿病患者的这一特定障碍。该项目由两个部分组成。弗吉尼亚大学人工胰腺开发中心的领导小组
我们建议利用糖尿病技术和伊利诺伊理工学院糖尿病研究和教育中心的广泛技术组合、闭环算法、运动检测和量化以及建模来实现以下特定目标: 1. 针对患者的特定目标。运动风险警报系统在运动开始时通知患者可能发生低血糖,其基于:(i) 使用 DiAs 云功能调整每个患者的风险检测器,以及 (ii) 基于个性化模拟的治疗适应建议 2。运动知情的自动胰岛素剂量:升级到 AP 控制系统,使用运动感应来跟踪代谢风险并调整胰岛素以维持安全的 BG 水平 3. 完全集成的运动适应 AP 系统:我们发现运动知情的 AP 系统具有两者。前馈(1)和反馈(2)组件,将患者从强制性的额外装置中解放出来,将提高血糖安全性和技术接受度,我们将通过以下方式独立和协调地证明每个提议模块的可行性、安全性和有效性。三项人体临床试验:两项短期住院示范试验和一项最终长期(4 个月)家庭试验这项最终试验还将探索使用我们的平台锻炼的心理社会方面,并开始解决安全、依从性和技术等关键方面。我们期望所提出的系统能够通过创建新颖的数据基础设施和最佳运动控制算法来增强 AP 在现实生活中的安全性和有效性,该项目还有可能为其他系统生成临床相关的衍生产品。治疗方式。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
Automatically accounting for physical activity in insulin dosing for type 1 diabetes.
- DOI:10.1016/j.cmpb.2020.105757
- 发表时间:2020-12
- 期刊:
- 影响因子:6.1
- 作者:Ozaslan B;Patek SD;Fabris C;Breton MD
- 通讯作者:Breton MD
In Silico Analysis of an Exercise-Safe Artificial Pancreas With Multistage Model Predictive Control and Insulin Safety System.
- DOI:10.1177/1932296819879084
- 发表时间:2019-11-01
- 期刊:
- 影响因子:5
- 作者:Garcia-Tirado, Jose;Colmegna, Patricio;Breton, Marc D
- 通讯作者:Breton, Marc D
Improving Glucose Prediction Accuracy in Physically Active Adolescents With Type 1 Diabetes.
- DOI:10.1177/1932296818820550
- 发表时间:2019-07-01
- 期刊:
- 影响因子:5
- 作者:Hobbs, Nicole;Hajizadeh, Iman;Cinar, Ali
- 通讯作者:Cinar, Ali
Safety and Feasibility Evaluation of Step Count Informed Meal Boluses in Type 1 Diabetes: A Pilot Study.
1 型糖尿病中步数知情膳食推注的安全性和可行性评估:一项试点研究。
- DOI:10.1177/1932296821997917
- 发表时间:2022
- 期刊:
- 影响因子:5
- 作者:Ozaslan,Basak;Brown,SueA;Pinnata,Jennifer;Barnett,CharlotteL;Carr,Kelly;Wakeman,ChristianA;Clancy-Oliveri,Mary;Breton,MarcD
- 通讯作者:Breton,MarcD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARC D BRETON其他文献
MARC D BRETON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARC D BRETON', 18)}}的其他基金
Advanced Artificial Pancreas Systems to Enable Fully Automated Glycemic Control in Type 1 Diabetes Mellitus
先进的人工胰腺系统可实现 1 型糖尿病的全自动血糖控制
- 批准号:
10676903 - 财政年份:2021
- 资助金额:
$ 297.99万 - 项目类别:
Advanced Artificial Pancreas Systems to Enable Fully Automated Glycemic Control in Type 1 Diabetes Mellitus
先进的人工胰腺系统可实现 1 型糖尿病的全自动血糖控制
- 批准号:
10276560 - 财政年份:2021
- 资助金额:
$ 297.99万 - 项目类别:
Advanced Artificial Pancreas Systems to Enable Fully Automated Glycemic Control in Type 1 Diabetes Mellitus
先进的人工胰腺系统可实现 1 型糖尿病的全自动血糖控制
- 批准号:
10488207 - 财政年份:2021
- 资助金额:
$ 297.99万 - 项目类别:
Translation of the UVA Advanced Automated Insulin Delivery Systems to Clinical Care in Young Children: Glycemic Control, Regulatory Acceptance and Optimization of Day to Day Use
UVA 先进自动胰岛素输送系统在幼儿临床护理中的应用:血糖控制、监管接受和日常使用优化
- 批准号:
10474818 - 财政年份:2021
- 资助金额:
$ 297.99万 - 项目类别:
Artificial Pancreas - Adolescent Physiology and Psychology Longitudinal Evaluation (A.P. APPLE)
人工胰腺 - 青少年生理学和心理学纵向评估 (A.P. APPLE)
- 批准号:
10381710 - 财政年份:2020
- 资助金额:
$ 297.99万 - 项目类别:
Translation of the UVA Advanced Automated Insulin Delivery Systems to Clinical Care in Young Children: Glycemic Control, Regulatory Acceptance and Optimization of Day to Day Use
UVA 先进自动胰岛素输送系统在幼儿临床护理中的应用:血糖控制、监管接受和日常使用优化
- 批准号:
10265602 - 财政年份:2020
- 资助金额:
$ 297.99万 - 项目类别:
Translation of the UVA Advanced Automated Insulin Delivery Systems to Clinical Care in Young Children: Glycemic Control, Regulatory Acceptance and Optimization of Day to Day Use
UVA 先进自动胰岛素输送系统在幼儿临床护理中的应用:血糖控制、监管接受和日常使用优化
- 批准号:
10470808 - 财政年份:2020
- 资助金额:
$ 297.99万 - 项目类别:
Artificial Pancreas - Adolescent Physiology and Psychology Longitudinal Evaluation (A.P. APPLE)
人工胰腺 - 青少年生理学和心理学纵向评估 (A.P. APPLE)
- 批准号:
10597623 - 财政年份:2020
- 资助金额:
$ 297.99万 - 项目类别:
HYPOGLYCEMIA PREVENTION AFTER EXERCISE IN ADOLESCENT T1DM
青少年 T1DM 运动后低血糖的预防
- 批准号:
8167207 - 财政年份:2010
- 资助金额:
$ 297.99万 - 项目类别:
FEASIBILITY STUDY OF A MODULAR CONTROL TO RANGE SYSTEM IN T1DM
T1DM 测距系统模块化控制的可行性研究
- 批准号:
8167201 - 财政年份:2010
- 资助金额:
$ 297.99万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 297.99万 - 项目类别:
Identification of gene variants mediating the behavioral and physiological response to THC
鉴定介导 THC 行为和生理反应的基因变异
- 批准号:
10660808 - 财政年份:2023
- 资助金额:
$ 297.99万 - 项目类别:
Determining medications associated with drug-induced pancreatic injury through novel pharmacoepidemiology techniques that assess causation
通过评估因果关系的新型药物流行病学技术确定与药物引起的胰腺损伤相关的药物
- 批准号:
10638247 - 财政年份:2023
- 资助金额:
$ 297.99万 - 项目类别:
TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer
分级姑息治疗:基于人群的护理提供模式,以满足不断变化的患者需求,并为社区心力衰竭或癌症患者提供姑息治疗服务
- 批准号:
10880994 - 财政年份:2023
- 资助金额:
$ 297.99万 - 项目类别: